Le Lézard
Classified in: Health, Science and technology
Subject: TDS

@-Health Unveils the Future of E-health at CES 2018



AIX-EN-PROVENCE, France, December 8, 2017 /PRNewswire/ --

Stand 50023 - Espace Provence Alpes Côte d'Azur 

@-Health, a company specializing in e-cardiology, will be participating for the first time at the CES (Consumer Electric Show), the unmissable event of the world's high-tech, to be held from January 9-12, 2018 in Las Vegas. With the support of French Tech Aix-Marseille, the Aix-based company will present CardioNexion, the first connected medical device for the ultra-early detection and analysis, in real time and continuously, of all cardiovascular pathologies.

     (Logo: http://mma.prnewswire.com/media/617024/Health_Logo.jpg )

Cardiovascular disease is the leading cause of death worldwide according to WHO. In the face of this global public health challenge, @ -Health is setting its sights on being a leading player. By participating in CES 2018, the company intends to demonstrate the relevance of CardioNexion to US investors and find potential partners.

Recall that CardioNexion is a connected medical device that continuously monitors real-time cardiac activity by specialists in cardiology.

It can detect and prevent with certainty any pathology whose first sign is a change in heart rate: stroke, atrial fibrillation, heart failure, sudden infant death, influenza... well before the first symptoms appear.

CardioNexion is also a new tool for practitioners. Indeed, it allows the attending physician to prescribe appropriate treatment and control its effectiveness in real time: a world first!

Specifically, for the patient, the device is in the form of a T-shirt or bra with smart sensors that monitor in real time 24/24 - 365 / day / year many essential data for its health.

This totally ambulatory, non-invasive and autonomous device allows to have the same medical supervision as in an intensive care unit. Via the patient's smartphone, anonymized data, collected 24 hours a day, are sent to secure servers, where they will be analyzed using a proprietary algorithm. They are then transported to a surveillance platform where a team of cardiologists and intensive care unit nurses are ready to respond. If a problem is detected, the patient's doctor is notified. In the most serious cases, "911" is directly called.

FOR MORE INFORMATION 


These press releases may also interest you

at 20:41
Aptinyx Inc. , a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced the pricing of its initial public offering of 6,399,999 shares of its common stock at a public...

at 20:05
Kezar Life Sciences, Inc. , a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer, announced today that it has priced its initial public offering of...

at 20:00
SCOTTSDALE, Ariz., June 20, 2018 /PRNewswire-PRWeb/ -- Arizona pain management doctor Nikesh Seth of Integrated Pain Consultants was named one of PHOENIX Magazine's Top Doctors for the fourth straight year. Top Doctors is a peer-selected list of the...

at 19:57
Wellcoaches announced a partnership with CoreHealth Technologies to deliver wellcoacheshabits©, an e-course focused on habits, the simplest and smallest unit of behavior and mindset that improves your performance and well-being. Habit-making is how...

at 19:24
Ramzan M. Zakir, M.D., F.A.CC., FSCAI is recognized by Continental Who's Who as 2018 Cardiologist of The Year in the field of Medicine in recognition of his role as Interventional Cardiologist at Heart & Vascular Institute of Central New Jersey....

at 19:24
Lynn Ge-Zerbe, M.D., M.P.H., is recognized by Continental Who's Who as a Pinnacle Professional Member in the field of Medicine in recognition of her role as Endocrinologist at Boise Thyroid-Endocrinology, PC.          A direct, concierge care...




News published on 7 december 2017 at 20:00 and distributed by: